Intraoperative Imaging Market size is projected to make consistent strides between 2022 and 2028, thanks to the growing adoption of minimally invasive disorders worldwide. Since intraoperative imaging devices verify surgical accuracy, ensuring that implants are placed in the appropriate place, the rising procedural volume is one of the primary growth drivers of the market forecast.
The intraoperative imaging market share from the oncology segment will register high revenue by 2028. Due to the upsurge in the number of brain tumor patients, there is a growing need for effective imaging equipment across healthcare organizations. As per the estimates of Cancer.Net, both adult and pediatric patients are being diagnosed with cancerous brain tumors. In 2021, more than 10,690 women and 13,840 men across the United States were found to be suffering from primary cancerous tumors of the spinal cord and brain.
Despite the concerns regarding radiation exposure, the number of CT scan procedures has been augmenting constantly. More than 80 million CT scans are performed every year in the United States alone. MRI systems and CT scanners are effective diagnostic tools used in the detection of a wide range of disorders and injuries. The growing product installation across hospitals and clinics is fueling the intraoperative CT scanner market share, as these tools are an important part of the surgical setup for spine surgery, neurological surgeries, and other procedures.
The intraoperative MRI systems market share from the ENT surgery segment is likely to register a high growth rate, owing to the rising exposure to occupational hearing hazards. With considerable support from private and public funds, ENT devices are becoming more non-invasive. As the concerns associated with respiratory system has increased due to the novel coronavirus, accurate diagnosis of throat and nose conditions is gaining more significance, thereby powering intraoperative imaging market outlook.
Owing to the mounting backlog of pending cases due to the pandemic, the intraoperative imaging industry share from the orthopedic surgery segment is expanding at a noteworthy pace. Big and small hospitals across the region have been intermittently putting orthopedic surgeries on hold during the pandemic, in order to accommodate more COVID-19 patients. The large number of postponed cases is generating a massive demand for shoulder, knee, and hip replacement procedures.
Europe intraoperative imaging market size is projected to grow steadily over 2028, triggered by the growing cancer inpatient volume across Germany, Italy, and Russia. According to the 2020 estimates by the European Commission’s Joint Research Center (JRC), cancer burden across the region rose to 2.7 million fresh cases, accounting for over 1.3 million deaths during 2020. Regional governments and the EU have been formulating favorable policies, including the InvestEU program, which will accelerate product deployment.
Top intraoperative imaging technology companies in the international landscape are focusing on product launches, mergers, acquisitions, and partnerships. In December 2021, Germany-based leader in the field of medical technology, Siemens Healthineers, announced that it has launched the world’s premier CT scanner that features photon-counting technology.
With enhanced image quality than conventional medical imaging devices, the Naeotom Alpha is designed for reduced radiation dose and increased resolution. Having received regulatory approval across the U.S. and Europe, the product is likely to broaden the company’s global footprint.
Siemens Heathineers General Electric, Medtronic, Toshiba, Koninklijke Philips N.V., and IMRIS, Inc. are some leading intraoperative imaging companies.
Following the cancellation of non-urgent surgical procedures during the worldwide lockdowns in 2020, the intraoperative imaging industry saw a decline in revenue. In December 2021, several hospitals across the U.S., including Banner Health and Cleveland Clinic, again suspended nonessential procedures amidst the omicron variant surge. Nonetheless, global vaccination drives, coupled with resumption of elective surgeries, is likely to add momentum to the market through 2028.
Market, By Product
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries: